Rheumatology International

, Volume 29, Issue 1, pp 107–110 | Cite as

Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy

  • Hatice Bodur
  • Ümit Seçkin
  • Filiz Eser
  • Gülüşan Ergül
  • Selda Seçkin
Case Report

Abstract

Familial Mediterranean fever (FMF) is a self-limited disease characterized by fever and polyserositis attacks. Arthritis caused by synovitis is either in acute monoarthritis or chronic mono-oligoarthritis form, usually affecting the lower extremities. Another potential but rare form of involvement is spondyloarthropathy (SSpA). Psoriatic arthritis (PsA) is inflammatory arthropathy of peripheral joints, spine and enthesis areas. Some PsA cases are classified as psoriatic spondyloarthropathy. A 43-year-old male patient with concomitant FMF and psoriasis presenting with bilateral sacroiliitis, chronic hip and knee arthritis has been presented along with follow-up findings and treatment options used.

Keywords

Familial Mediterranean fever Psoriatic arthritis 

Notes

Conflict of interest

There is no conflict of interest either financial or other relationships. H Bodur, Ü Seçkin, F Eser, G Ergül, S Seçkin.

Reference

  1. 1.
    Balaban B, Yaşar E, Ozgül A, Dincer K, Kalyon TA (2005) Sacroiliitis in familial Mediterranean fever and seronegative spondyloarthropathy: importance of differential diagnosis. Rhematol Int 25:641–644CrossRefGoogle Scholar
  2. 2.
    Beşbaş N, Özdemir S, Saatçi I, Bakkaloğlu A, Özen S, Saatçi Ü (1999) Sacroiliitis in familial Mediterranean fever. an usual presentation in childhood. Turk J Pediatr 41:387–390PubMedGoogle Scholar
  3. 3.
    Langevitz P, Livneh A, Zemer D, Shemer J, Pras M (1997) Seronegative spondyloarthropathy in Familial Mediterranean Fever. Arthritis Rheum 27(2):67–72CrossRefGoogle Scholar
  4. 4.
    Majeed HA, Rawashdeh M (1996) The clinical patterns of arthritis in children with familial Mediterranean fever. Q J Med 90:37–43Google Scholar
  5. 5.
    Incel NA, Saraçoğlu M, Erdem HR (2003) Seronegative spondyloarthropathy of familial Mediterranean fever. Rhematol Int 23:41–43Google Scholar
  6. 6.
    Birlik M, Tunca M, Hızlı N, Soytürk M, Yeniçerioğlu Y, Özcan MA, El Ö (1998) Coexistence of familial Mediterranean fever with sacroiliitis and Behçet’s disease: a rare occurence. Clin Rheumatol 17:397–399PubMedCrossRefGoogle Scholar
  7. 7.
    Gladman DD (2005) Familial autoinflammatory syndromes. In: Kelley’s textbook of rheumatology, 7th edn. vol 2, pp 1773–1788Google Scholar
  8. 8.
    Bodur H, Ucan H, Seckin U, Gunduz OH (1999) Protracted familial Mediterranean fever arthritis. Rheumatol Int 19:71–73PubMedCrossRefGoogle Scholar
  9. 9.
    Livneh A, Langevitz P (2000) Diagnostic and treatment concerns in familial Mediterranean fever. Baillieres Best Pract Res Clin Rheumatol 14(3):477–498PubMedCrossRefGoogle Scholar
  10. 10.
    Turkiewicz AM, Moreland LW (2007) Psoriatic arthritis current concept on pathogenesis-oriented therapeutic options. Arthritis Rheum 56(4):1051–1066PubMedCrossRefGoogle Scholar
  11. 11.
    Mease P (2006) Psoriatic arthritis update. Bull NYU Hosp Jt Dis 64(1–2):25–31PubMedGoogle Scholar
  12. 12.
    Gladman DD, Antoni C, Mease P, Mease DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course and outcome. Ann Rheum Dis: 64 (Suppl 2):ii14–ii17Google Scholar
  13. 13.
    Yeniay BS, Karaca NE, Yuksel SE, Midyat L, Kutukculer N (2007) Juvenile psoriatic arthritis carrying familial Mediterranean fever gene mutations in a 14-year-old Turkish girl. J Dermatol 34:344–348PubMedGoogle Scholar
  14. 14.
    Kyle S, Chandler D, Griffiths CEM, Helliwell P, Lewis J, McInnes I et al (2005) Guideline for anti-TNFα therapy in psoriatic arthritis. Rheumatology 44:390–397PubMedCrossRefGoogle Scholar
  15. 15.
    Mease PJ, Antoni CE, Gladman DD, Taylor WJ (2005) Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis 64(Suppl 2):ii49–ii54PubMedCrossRefGoogle Scholar
  16. 16.
    Sakallıoglu O, Duzova A, Ozen S (2006) Etanercept in treatment of arthritis in a patient with familial Mediterranean fever. Clin Exp Rheumatol 24:435–437PubMedGoogle Scholar
  17. 17.
    Seyahi E, Ozdogan H, Celik S, Ugurlu S, Yazici H (2006) Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin Exp Rheumatol 24(Suppl 42):99–103Google Scholar
  18. 18.
    Mor A, Pillinger MH, Kishimato M, Abeles AM, Livneh A (2007) Familial Mediterranean fever successfully treated with etanercept. J Clin Rheumatol 13:38–40PubMedCrossRefGoogle Scholar
  19. 19.
    Ozgocmen S, Ozcakar L, Ardicoglu O, Kocakoc E, Kaya A, Kiris A (2005) Familial Mediterranean fever responds well to infliximab: single case experince. Clin Rheumatol 25:83–87PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Hatice Bodur
    • 1
    • 3
  • Ümit Seçkin
    • 1
  • Filiz Eser
    • 1
  • Gülüşan Ergül
    • 2
  • Selda Seçkin
    • 2
  1. 1.Deparment of Physical Medicine and RehabilitationAnkara Numune Education and Research HospitalAnkaraTurkey
  2. 2.Deparment of PathologyAnkara Numune Education and Research HospitalAnkaraTurkey
  3. 3.AnkaraTurkey

Personalised recommendations